Clinical Trial Update: A Study to Assess the PK and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial updates the pharmacokinetics and pharmacodynamics of IPX203 in adults with advanced Parkinson's disease; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• IPX203

Snippet

Sponsor: Impax Laboratories, LLC | Conditions: Advanced Parkinson's Disease | Phase 2 | Status: COMPLETED | Results posted: 2022-06-06